Literature DB >> 28565807

Arsenic trioxide increases expression of secreted frizzled-related protein 1 gene and inhibits the WNT/β-catenin signaling pathway in Jurkat cells.

Yan Wang1, Zunsong Wang2, Hong Li1, Wenwei Xu1, Lin Dong1, Yan Guo1, Saran Feng1, Kehong Bi1, Chuansheng Zhu1.   

Abstract

The aim of the present study was to investigate the demethylation effect of arsenic trioxide (As2O3) on the secreted frizzled-related protein 1 (SFRP1) gene and its ability to inhibit the Wingless-type MMTV integration site family (WNT) pathway in Jurkat cells. Methylation-specific polymerase chain reaction was used to examine the CpG island methylation status of the SFRP1 gene in leukemia cell lines. In addition, the effects on Jurkat cells of treatment with different concentrations of As2O3 for 48 h were investigated. Reverse transcription-quantitative polymerase chain reaction was employed to measure the expression of mRNAs, while western blot analysis was used to examine protein expression in cells. The SFRP1 gene was methylated in Jurkat cells. However, both methylated and unmethylated SFRP1 genes were detected in HL60 and K562 cells. In normal bone marrow mononuclear cells, the SFRP1 gene was unmethylated. Following treatment with As2O3 for 48 h, the SFRP1 gene was demethylated, and the mRNA and protein expression levels of the SFRP1 gene were increased. By contrast, the mRNA and protein expression levels of β-catenin and cyclin Dl were downregulated. The protein expression of c-myc was also downregulated, but As2O3 exhibited no significant effect on the mRNA expression of c-myc. Abnormal methylation of the SFRP1 gene was detected in Jurkat cells. These results suggest that As2O3 activates SFRP1 gene expression at the mRNA and protein levels in Jurkat cells by demethylation of the SFRP1 gene. Furthermore, they indicate that As2O3 regulates WNT target genes and controls the growth of Jurkat cells through the WNT/β-catenin signaling pathway.

Entities:  

Keywords:  SFRP1 gene; WNT/β-catenin signaling pathway; arsenic trioxide; leukemia; methylation

Year:  2017        PMID: 28565807      PMCID: PMC5443245          DOI: 10.3892/etm.2017.4184

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  39 in total

1.  Methylation of secreted frizzled related protein gene in acute leukemia patients in China.

Authors:  Jian-Zhen Shen; Cheng-Bo Xu; Hai-Ying Fu; Dang-Sen Wu; Hua-Rong Zhou; Li-Ping Fan
Journal:  Asian Pac J Cancer Prev       Date:  2011

2.  [The significance of methylation status of secreted frizzled-related protein gene promoter in acute leukemia].

Authors:  Cheng-bo Xu; Jian-zhen Shen; Song-fei Shen; Hai-ying Fu; Yi-fang Zhu; Lu Chen
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2010-09

3.  Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor.

Authors:  C-S Chim; W W-L Chan; A Pang; Y-L Kwong
Journal:  Leukemia       Date:  2006-05       Impact factor: 11.528

Review 4.  Mechanisms of Wnt signaling in development.

Authors:  A Wodarz; R Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

5.  [Abnormal methylation patterns of SFRP1 gene in cells of leukemia and inhibition of arsenic trioxide on the SFRP1 gene].

Authors:  Yan Wang; Xun-xun Zhu; Chuan-sheng Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2013-02

6.  Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.

Authors:  Elizabeth A Griffiths; Steven D Gore; Craig Hooker; Michael A McDevitt; Judith E Karp; B Douglas Smith; Helai P Mohammad; Ying Ye; James G Herman; Hetty E Carraway
Journal:  Leuk Lymphoma       Date:  2010-09

7.  Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death.

Authors:  I Tarkanyi; C Dudognon; J Hillion; F Pendino; M Lanotte; J Aradi; E Ségal-Bendirdjian
Journal:  Leukemia       Date:  2005-10       Impact factor: 11.528

8.  Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.

Authors:  Hanlin L Wang; Julia Wang; Shu-Yuan Xiao; Rex Haydon; Debra Stoiber; Tong-Chuan He; Marc Bissonnette; John Hart
Journal:  Int J Cancer       Date:  2002-10-01       Impact factor: 7.396

9.  Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes.

Authors:  Xiao Shuai; Daobin Zhou; Ti Shen; Yongji Wu; Jieping Zhang; Xuan Wang; Qian Li
Journal:  Cancer Genet Cytogenet       Date:  2009-10-15

Review 10.  The significance of the Wnt pathway in the pathology of human cancers.

Authors:  Rooshdiya Karim; Gary Tse; Thomas Putti; Richard Scolyer; Soon Lee
Journal:  Pathology       Date:  2004-04       Impact factor: 5.306

View more
  2 in total

1.  Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia.

Authors:  Jing Hua; Congcong Ma; Chao Hui Wang; Yan Wang; Saran Feng; Taiwu Xiao; ChuanSheng Zhu
Journal:  Appl Bionics Biomech       Date:  2022-07-09       Impact factor: 1.664

Review 2.  The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus.

Authors:  Ling-Bin Liu; Xiao-Dong Chen; Xiang-Yu Zhou; Qing Zhu
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.